CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 229,902	$ 145,054
Marketable securities	193,436	152,167
Total cash, cash equivalents, and marketable securities	423,338	297,221
Accounts receivable, net	300,173	255,150
Unbilled receivables, net	237,379	213,719
Other current assets	68,137	80,388
Total current assets	1,029,027	846,478
Long-term unbilled receivables, net	85,402	95,806
Goodwill	81,611	81,399
Other long-term assets	314,696	333,989
Total assets	1,510,736	1,357,672
Current liabilities:
Accounts payable	11,290	18,195
Accrued expenses	39,941	50,355
Accrued compensation and related expenses	126,640	127,728
Deferred revenue	377,845	325,212
Other current liabilities	21,343	17,450
Total current liabilities	577,059	538,940
Long-term convertible senior notes, net	499,368	593,609
Long-term operating lease liabilities	66,901	79,152
Other long-term liabilities	13,570	15,128
Total liabilities	1,156,898	1,226,829
Commitments and contingencies (Note 20)
Stockholders’ equity:
Preferred stock, $0.01 par value, 1,000 shares authorized; none issued	0	0
Common stock, $0.01 par value, 200,000 shares authorized; 83,840 and 82,436 shares issued and outstanding as of December 31, 2023 and 2022, respectively	838	824
Additional paid-in capital	379,584	229,602
(Accumulated deficit)	(8,705)	(76,513)
Accumulated other comprehensive (loss)
Net unrealized gain on available-for-sale securities, net of tax	669	517
Foreign currency translation adjustments	(18,548)	(23,587)
Total stockholders’ equity	353,838	130,843
Total liabilities and stockholders’ equity	$ 1,510,736	$ 1,357,672